LUNG CANCER NON SMALL CELL

This study tests whether adding two immunotherapy drugs (cobolimab and dostarlimab) to standard chemotherapy (docetaxel) helps people with advanced non-small cell lung cancer live longer. The trial includes about 758 adults whose cancer worsened after prior chemotherapy and immun…

This study compares three treatments for lung tumors: surgery, targeted radiation (SBRT), and a minimally invasive procedure called thermal ablation that uses heat or cold to destroy cancer cells. About 100 adults in Lithuania will be followed for two years to see which approach …

This study tests a new combination of two drugs (belrestotug and dostarlimab) against the current standard treatment (pembrolizumab) in people with advanced non-small cell lung cancer that has not been treated before. The goal is to see if the new combo is safer and works better.…

This study is testing new combinations of immunotherapy drugs in people with advanced non-small cell lung cancer that has not been treated before. Participants must have high levels of a protein called PD-L1 on their tumors. The main goal is to check the safety of these drug comb…

This study tests a 12-week program called Breathe Easier+ for people who have finished treatment for non-small cell lung cancer and their partners. The program includes guided walking, resistance training, and meditation done at home using a tablet and Fitbit. The goal is to see …

This study looks at whether providing medically tailored meals and nutrition counseling can help vulnerable lung cancer patients eat better, manage treatment side effects, and improve their quality of life. About 270 patients from diverse and underserved backgrounds will take par…

This study tests a tool that helps lung cancer patients and their doctors decide together on the radiation dose for tumors near the chest wall. About 40 adults with non-small cell lung cancer or lung metastases will use a Patient Decision Aid during their consultation. The goal i…